Frankfurt (Reuters) – Mainz biotech company BionTech has secured around $ 250 million in fresh capital from investors.
Donors include Singapore’s Temasek sovereign wealth fund, as BionTech announced on Monday. …
google-site-verification=RoadygaH2N3jsP-zBochCrn0ABtnedK76rnS7kMfyOU